Related Experiment Video
Updated: Sep 19, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Implementing a Model-Informed Precision Dosing Service for Cefepime in a Quaternary Children's Hospital: A First-Year
Ronaldo Morales Junior1, Emily Diseroad2, Shannon Reinert1,3
1Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Background:
This study describes the first-year experience with a model-informed precision dosing (MIPD) consultation service for cefepime at a quaternary children's hospital, including patient characteristics, turnaround times, process barriers, and the impact of dosing recommendations.
Methods:
This prospective observational study included data from all cefepime MIPD consultations from August 2024 to August 2025. Demographic, clinical, microbiologic, and treatment data were obtained from electronic health records. Timeliness was evaluated by tracking timestamps from consult order to result communication and dose adjustment. The analysis examined whether recommendations led to changes in dose, dosing frequency, or infusion duration.
Results:
Nineteen patients (median age 2.7 years, range 1 month-27.7 years) received a total of 20 cefepime MIPD consultations. Infection sources included bloodstream, abdomen, respiratory tract, central nervous system, peritoneal dialysis catheter, and urine. Half of the patients required extracorporeal support. Organisms were isolated in 10 patients (cefepime MICs <0.12-8 mg/L), whereas others were dosed empirically. Recommendations were provided a median of 27.8 hours after consultation order (range 6.6-82.4 hours). Eight (40%) recommendations supported continuing the existing regimen, and 10 (50%) resulted in new dosing strategies. In 1 case (5%), cefepime was changed to meropenem owing to concern about possible neurotoxicity, and in another, the family opted for comfort-focused care before recommendations could be provided. Challenges included logistical barriers, communication gaps, insufficient training, system limitations, and clinical issues.
Conclusions:
These findings support the feasibility and clinical utility of an MIPD consultation service for cefepime. The service enabled timely identification of high or low exposures, including in patients on extracorporeal support, and guided individualized dosing decisions to optimize target attainment.
Related Concept Videos
Drug Dosing: Infants and Children
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacokinetics in Pediatric Patients: Drug Distribution
Dosage Regimens: Designs and Approaches
Estimation of k and VD of Aminoglycosides
